BeOne Medicines: The Capital Group Companies, Inc. Acquires Shares
HK Disclosure
Sep 28
The Capital Group Companies, Inc. bought 1.95 million shares of BEONE MEDICINES on the SEHK open market at an average of USD 358.7693 per share on September 24, 2026, involving about USD 699.40 million. This is an on-exchange active trade, i.e., a direct dealing in the secondary market.
Prior to the acquisition, The Capital Group Companies, Inc.'s long position in BEONE MEDICINES was 122.60 million shares, representing 7.95%; following the acquisition, the holding changed to 124.55 million shares, with the long position ratio rising to 8.08%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.